Vensica Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $19M

  • Investors
  • 9

Vensica General Information

Description

Developer of an ultrasound-based drug delivery system designed to treat overactive bladder (OAB). The company's system leverages the known properties of ultrasound and is needle-free and the drug will be instilled in a quick, pain-free procedure after the delivery of ultrasound to the urinary bladder to improve the treatment and reduce recurrence rates, enabling medical professionals to safely and effectively deliver treatment to patients suffering from urinary overactive bladder.

Contact Information

Website
www.vensica.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Therapeutic Devices
Corporate Office
  • HaGavish Street 4
  • Netanya 4250706
  • Israel
+972 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vensica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 07-Feb-2022 $19M 000.00 Completed Generating Revenue
3. Corporate 02-Oct-2017 000 00.00 Completed Generating Revenue
2. Angel (individual) 19-Jul-2016 $500K $500K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Vensica’s complete valuation and funding history, request access »

Vensica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an ultrasound-based drug delivery system designed to treat overactive bladder (OAB). The company's system l
Drug Delivery
Netanya, Israel
6 As of 2024
000.00
0000000000 0 000.00

000000

in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint o
00000000000 0000000
Paris, France
00 As of 0000
0000
000.00 0000-00-00
00000000000 0000

000000

ed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad min
00000000000 0000000
Milan, Italy
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vensica Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
HighLife Venture Capital-Backed Paris, France 00 0000 00000000000 0000
InnovHeart Venture Capital-Backed Milan, Italy 00 000.00 00000000000 000.00
Valcare Venture Capital-Backed Herzliya, Israel 00 000.00 00000000000 000.00
Kardium Venture Capital-Backed Burnaby, Canada 000 00000 0000000000 0 00000
Urogen Pharma Formerly VC-backed Princeton, NJ 000 00000 000000000 00000
You’re viewing 5 of 14 competitors. Get the full list »

Vensica Patents

Vensica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019249430-A1 System and method for ultrasonic bladder therapeutic agent delivery Active 01-Apr-2018 00000000000
CA-3095598-A1 System and method for ultrasonic bladder therapeutic agent delivery Pending 01-Apr-2018 00000000000
US-20210052873-A1 System and method for ultrasonic bladder therapeutic agent delivery Active 01-Apr-2018 000000000
US-11529506-B2 System and method for ultrasonic bladder therapeutic agent delivery Active 01-Apr-2018 000000000 00
EP-3773262-A4 System and method for ultrasonic bladder therapeutic agent delivery Pending 01-Apr-2018 A61M37/0092 0
To view Vensica’s complete patent history, request access »

Vensica Executive Team (2)

Name Title Board Seat
Avner Geva Co-Founder & Chief Executive Officer
Avi Eftel Chief Technology Officer
To view Vensica’s complete executive team members history, request access »

Vensica Board Members (4)

Name Representing Role Since
Edit Goldberg Self Board Member 000 0000
Eran Feldhay MD Trendlines Board Member 000 0000
Nissim Darvish Ph.D Self Chairman 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Vensica Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vensica Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Agriline Corporation Minority 000 0000 000000 0
Israel Biotech Fund Venture Capital Minority 000 0000 000000 0
Merz Pharma Corporation Minority 000 0000 000000 0
Cogentix Medical PE-Backed Company Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Vensica FAQs

  • When was Vensica founded?

    Vensica was founded in 2014.

  • Who is the founder of Vensica?

    Avner Geva is the founder of Vensica.

  • Who is the CEO of Vensica?

    Avner Geva is the CEO of Vensica.

  • Where is Vensica headquartered?

    Vensica is headquartered in Netanya, Israel.

  • What is the size of Vensica?

    Vensica has 6 total employees.

  • What industry is Vensica in?

    Vensica’s primary industry is Drug Delivery.

  • Is Vensica a private or public company?

    Vensica is a Private company.

  • What is Vensica’s current revenue?

    The current revenue for Vensica is 00000.

  • How much funding has Vensica raised over time?

    Vensica has raised $21.5M.

  • Who are Vensica’s investors?

    Agriline, Israel Biotech Fund, Merz Pharma, Cogentix Medical, and Israel Innovation Authority are 5 of 9 investors who have invested in Vensica.

  • Who are Vensica’s competitors?

    HighLife, InnovHeart, Valcare, Kardium, and Urogen Pharma are some of the 14 competitors of Vensica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »